isocarboxazid has been researched along with Pyrexia in 3 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellervik, C | 1 |
| Høgholm, A | 1 |
| Nielsen, K | 1 |
| Schuckit, M | 1 |
| Robins, E | 1 |
| Feighner, J | 1 |
3 other studies available for isocarboxazid and Pyrexia
| Article | Year |
|---|---|
[Prolonged hyperthermia after isocarboxazid poisoning].
Topics: Adult; Antidepressive Agents; Fever; Humans; Isocarboxazid; Male; Suicide, Attempted | 2003 |
[Hyperpyrexia following poisoning with a monoamine oxidase inhibitor].
Topics: Adult; Female; Fever; Humans; Isocarboxazid; Pancuronium; Suicide, Attempted | 1989 |
Tricyclic antidepressants and monoamine oxidase inhibitors.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amitriptyline; Animals; Depression; Desipramine; Drug | 1971 |